Biotechnology
16 December 2024 A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares insights into the defence strategy that led to the win.
12 December 2024
5 December 2024
3 December 2024
28 November 2024
26 November 2024
Latest Features
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone.
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
Biotechnology
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap.
Biotechnology
As artificial intelligence creates a complex legal landscape for healthcare and medtech, Janine Swarbrick of HGF explores two case studies that shed light on how to claim an AI invention.
Biotechnology
It is critical that the emerging field of personalised medicine receives appropriate patent protection, explain Joel Coles and Theo Cooper of Powell Gilbert.
Biotechnology
Agreeing to a dispute resolution mechanism in an international joint venture requires forward thinking, say Jens Petry and Tom Gassmann, Squire Patton Boggs.
More News
19 November 2024 Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages.
14 November 2024 Michael Summersgill and his co-counsel at WilmerHale secured more favourable outcomes for their clients than others in a series of lawsuits brought by Ravgen over pre-natal screening tests, he tells Sarah Speight.
12 November 2024 Sapna Palla joins the firm in New York, bringing significant experience in complex life sciences and IP disputes to a growing practice.
5 November 2024 A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | Case stemmed from a previous arbitration involving the chief scientific officer of Inhibrx | Jury found no evidence supporting opponents claims, awarding the plaintiff $0 damages.
29 October 2024 UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering haemophilia B therapies in the US, Canada and UK
24 October 2024 Regeneron loses bid to block Eylea copy at US appeals court | Biotech says decision ‘not the final word’ in litigation
22 October 2024 10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox